• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

农村地区乳腺癌治疗及时性的差异:乳腺癌治疗差异

Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.

作者信息

Orsi Carolina, Davis Tyler, Swindall Rebecca, Wadle Carly, Cook Alan, Ismael Hishaam

机构信息

Department of Graduate Medical Education, General Surgery, The University of Texas at Tyler Health Science Center, Tyler, TX, USA.

Department of Surgery, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.

出版信息

Ann Surg Oncol. 2025 Jul;32(7):4883-4889. doi: 10.1245/s10434-025-17291-z. Epub 2025 Apr 17.

DOI:10.1245/s10434-025-17291-z
PMID:40246744
Abstract

BACKGROUND

Evidence-based benchmarks have been established to assess the quality of breast cancer care, as delays in treatment correlate with poor clinical outcomes. Our aim was to identify factors influencing the timeliness of care within a rural East Texas healthcare system.

PATIENTS AND METHODS

Patients diagnosed with invasive breast cancer were identified and monitored from January 2015 to October 2022. Timeliness of care was assessed retrospectively across three intervals: diagnostic imaging to biopsy, biopsy to surgical treatment, and mammogram to surgical treatment. We analyzed correlations between demographic and clinical factors influencing timely initiation of treatment in our population against recommendations from the National Consortium of Breast Centers (NCBC).

RESULTS

A total of 278 cases were included over the 5-year study period. Nearly half met the recommended timeline from diagnostic imaging to biopsy, 13.3% from mammogram to surgical treatment, and 10.3% from biopsy to surgical treatment. A delay in the "diagnostic imaging to biopsy" interval or "biopsy to surgical treatment" interval predicted delays in the mammogram to treatment interval. Hispanics were more likely to present with stage 3 cancer and had a 4.5 times higher likelihood of mortality compared with Non-Hispanic whites.

CONCLUSIONS

Delay in one phase of care predicted delays in subsequent phases. Timeliness of treatment also influenced survival rates among Hispanic patients. Understanding factors influencing the timeliness of breast cancer treatment may guide targeted interventions in the future for patients at greater risk of care delays.

摘要

背景

鉴于治疗延迟与不良临床结果相关,已建立循证基准来评估乳腺癌护理质量。我们的目的是确定影响东德克萨斯州农村医疗系统内护理及时性的因素。

患者与方法

对2015年1月至2022年10月期间确诊为浸润性乳腺癌的患者进行识别和监测。通过回顾性分析评估三个阶段的护理及时性:诊断性成像至活检、活检至手术治疗以及乳房X线摄影至手术治疗。我们根据国家乳腺中心联盟(NCBC)的建议,分析了影响我们研究人群中及时开始治疗的人口统计学和临床因素之间的相关性。

结果

在5年的研究期间共纳入278例病例。近一半患者符合从诊断性成像到活检的推荐时间线,13.3%符合从乳房X线摄影到手术治疗的时间线,10.3%符合从活检到手术治疗的时间线。“诊断性成像至活检”阶段或“活检至手术治疗”阶段的延迟预示着乳房X线摄影至治疗阶段的延迟。西班牙裔患者更有可能出现3期癌症,其死亡率是非西班牙裔白人的4.5倍。

结论

一个护理阶段的延迟预示着后续阶段的延迟。治疗的及时性也影响西班牙裔患者的生存率。了解影响乳腺癌治疗及时性的因素可能会为未来对护理延迟风险更高的患者进行有针对性的干预提供指导。

相似文献

1
Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.农村地区乳腺癌治疗及时性的差异:乳腺癌治疗差异
Ann Surg Oncol. 2025 Jul;32(7):4883-4889. doi: 10.1245/s10434-025-17291-z. Epub 2025 Apr 17.
2
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺 X 线摄影联合乳腺超声与乳腺 X 线摄影用于一般风险女性乳腺癌筛查。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3.
3
Treatment Delays in the Hispanic Population With Renal Cell Carcinoma: An Analysis of Over 150,000 Patients Using the National Cancer Database.西班牙裔肾细胞癌患者的治疗延迟:使用国家癌症数据库对超过15万患者的分析。
Urol Pract. 2025 Jul;12(4):371-379. doi: 10.1097/UPJ.0000000000000801. Epub 2025 Jun 23.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
6
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Follow-up strategies for women treated for early breast cancer.早期乳腺癌女性患者的随访策略
Cochrane Database Syst Rev. 2016 May 27;2016(5):CD001768. doi: 10.1002/14651858.CD001768.pub3.
10
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.

本文引用的文献

1
Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.新诊断乳腺癌患者治疗启动的及时性。
Clin Breast Cancer. 2020 Feb;20(1):e27-e35. doi: 10.1016/j.clbc.2019.06.009. Epub 2019 Jul 11.
2
A Multidisciplinary Patient Navigation Program Improves Compliance With Adjuvant Breast Cancer Therapy in a Public Hospital.一项多学科患者导航计划改善了公立医院辅助性乳腺癌治疗的依从性。
Am J Med Qual. 2017 Jul/Aug;32(4):406-413. doi: 10.1177/1062860616656250. Epub 2016 Jun 29.
3
Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
种族差异对乳腺癌新辅助化疗的应用和结局的影响:来自国家癌症数据库的结果。
J Clin Oncol. 2015 Dec 20;33(36):4267-76. doi: 10.1200/JCO.2015.63.7801. Epub 2015 Nov 23.
4
Disparities in timeliness of care for U.S. Medicare patients diagnosed with cancer.美国医疗保险患者癌症诊断后护理及时性的差异。
Curr Oncol. 2012 Dec;19(6):e404-13. doi: 10.3747/co.19.1073.
5
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer.低收入乳腺癌女性确诊后治疗启动时间间隔延长对生存的影响。
J Clin Oncol. 2012 Dec 20;30(36):4493-500. doi: 10.1200/JCO.2012.39.7695. Epub 2012 Nov 19.
6
National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures.国家乳腺中心质量指标(NQMBC):一个强有力的质量工具:乳腺中心质量指标。
Ann Surg Oncol. 2010 Feb;17(2):377-85. doi: 10.1245/s10434-009-0729-5. Epub 2009 Oct 16.
7
Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients.早期女性乳腺癌患者接受淋巴结活检的差异。
Ann Surg Oncol. 2009 Mar;16(3):562-70. doi: 10.1245/s10434-008-0205-7. Epub 2008 Nov 8.
8
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.12种癌症确诊时保险状况及种族与癌症分期的关联:一项回顾性分析
Lancet Oncol. 2008 Mar;9(3):222-31. doi: 10.1016/S1470-2045(08)70032-9. Epub 2008 Feb 20.
9
Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer.一项基于人群的新诊断乳腺癌患者研究中与诊断时疾病晚期相关的因素。
Am J Epidemiol. 2007 Nov 1;166(9):1035-44. doi: 10.1093/aje/kwm177. Epub 2007 Aug 9.
10
Performance benchmarks for screening mammography.乳腺钼靶筛查的性能基准
Radiology. 2006 Oct;241(1):55-66. doi: 10.1148/radiol.2411051504.